Fill This Form To Receive Instant Help
Homework answers / question archive / NU670 Psychopharmacology and Health promotion Neurotransmitter Chart (Unit 2) Antipsychotics Chart (Unit 7) Antidepressants, Anxiolytics, & Mood Stabilizers Chart (Units 5, 6) Substance Use Resources (Chart links) (Units 11, 13, 14) Additional Resources List Neurotransmitters Chart Function (Excitatory or Inhibitory) Locations Receptors Effects of Deficient Effects of Surplus Agonist Drug Antagonist Drug Acetylcholine Dopamine Endorphins GABA Glutamate Glycine Glutamate Norepinephrine Serotonin Notes: Antipsychotics First Generation Side Effects (L=Low, M=Moderate, H=High) Generic Name Trade Name Route(s) of Administration LAI option Starting Dose Half Life Indications (s/sx & diagnosis) MOA (neurotransmitter effects) EPS Hyperlipidemia T2DM Weight Gain Cognitive Issue Other SE Costs Second Generation Notes: Antidepressants, Anxiolytics & Mood Stabilizers Antidepressants Side Effects (L=Low, M=Moderate, H=High) Generic Name Trade Name Route(s) of Administration LAI option Starting Dose Half Life Indications (s/sx & diagnosis) MOA (neurotransmitter effects) EPS Hyperlipidemia T2DM Weight Gain Cognitive Issue Other SE Costs SSRIs SNRIs TCAs MAOIs Atypical Anxiolytics Benzodiazepines Barbiturates Mood Stabilizers Notes: Substance Use Resources Commonly Used Drugs and Treatment Information Charts: https://www
NU670 Psychopharmacology and Health promotion
Neurotransmitter Chart (Unit 2)
Antipsychotics Chart (Unit 7)
Antidepressants, Anxiolytics, & Mood Stabilizers Chart (Units 5, 6)
Substance Use Resources (Chart links) (Units 11, 13, 14)
Additional Resources List
Neurotransmitters Chart
Function (Excitatory or Inhibitory) Locations Receptors Effects of Deficient Effects of Surplus Agonist Drug Antagonist Drug
Acetylcholine
Dopamine
Endorphins
GABA
Glutamate
Glycine
Glutamate
Norepinephrine
Serotonin
Notes:
Antipsychotics
First Generation Side Effects (L=Low, M=Moderate, H=High)
Generic Name Trade Name Route(s) of Administration LAI option Starting Dose Half Life Indications (s/sx & diagnosis) MOA (neurotransmitter effects) EPS Hyperlipidemia T2DM Weight Gain Cognitive Issue Other SE Costs
Second Generation
Notes:
Antidepressants, Anxiolytics & Mood Stabilizers
Antidepressants Side Effects (L=Low, M=Moderate, H=High)
Generic Name Trade Name Route(s) of Administration LAI option Starting Dose Half Life Indications (s/sx & diagnosis) MOA (neurotransmitter effects) EPS Hyperlipidemia T2DM Weight Gain Cognitive Issue Other SE Costs
SSRIs
SNRIs
TCAs
MAOIs
Atypical
Anxiolytics
Benzodiazepines
Barbiturates
Mood Stabilizers
Notes:
Substance Use Resources
Commonly Used Drugs and Treatment Information Charts:
https://www.drugabuse.gov/sites/default/files/Commonly-Used-Drugs-Charts_final_June_2020_optimized.pdf
https://www.drugabuse.gov/sites/default/files/nida_commonlyuseddrugs_final_printready.pdf
Withdrawal Sx Chart
https://www.drugabuse.gov/sites/default/files/nida_commonlyabused_withdrawalsymptoms_10062017-508-1.pdf